Myomo Working Capital

What does Myomo do? Myomo, Inc. generates revenue by selling its MyoPro product line, which consists of myoelectric-controlled upper limb braces designed for patients with neuromuscular disorders. The company directly sells these orthoses to patients and bills their insurance providers for coverage. The MyoPro enables users to control partially paralyzed limbs using their own muscle signals, supporting daily activities like eating and dressing. The target market includes adults and adolescents with conditions such as stroke, spinal cord injury, and brachial plexus injury. The MyoPro product line is marketed as a solution for functional improvement in upper limb paralysis, focusing on home and community use. Myomo’s devices are positioned to help patients regain independence in daily living tasks. Insurance reimbursement is a key revenue stream, with the company handling billing directly to insurers on behalf of patients. The primary customer segments are individuals with neuromuscular conditions requiring orthotic support for upper limb functionality. Myomo is one of the most popular companies on Eulerpool.